search
Back to results

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study

Primary Purpose

Kidney, Polycystic, Autosomal Dominant

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
video thorascopic splanchnicectomy (VSPL)
Sponsored by
Mayo Clinic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Kidney, Polycystic, Autosomal Dominant focused on measuring Polycystic Kidney Disease, Chronic Kidney Pain, Autosomal Dominant Polycystic Kidney, Kidney Cyst, VSPL, video thoracoscopic splanchnicectomy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 18 years or older
  • Diagnosis of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
  • History of debilitating kidney pain for at least 6 month. Other methods of pain management will have been appropriately considered and used when feasible and indicated.
  • Patient fit for general anesthesia
  • Must be able to travel to Mayo Clinic Rochester for 3 visits
  • Must be able to cover the cost of the surgery and post operative care.

Exclusion Criteria:

  • Pregnant women (must have a confirmed negative pregnancy test)
  • Nursing women
  • Creatinine > 3mg/dl, or hemodialysis dependent
  • Cancer and other major systemic diseases that could prevent follow-up or data interpretation
  • Neurologic or psychologic conditions preventing appropriate informed consent
  • Uncontrolled hypertension(SBP > 160; DBP >100)

Sites / Locations

  • Mayo Clinic

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

video thoracoscopic splanchnicectomy (VSPL)

Arm Description

Outcomes

Primary Outcome Measures

Improvement in pain control and quality of life

Secondary Outcome Measures

Changes in urine biomarkers compared to pre-operation values within patients will be compared. Changes in kidney volume, kidney cyst volume, and kidney blood flow before and after the operation will be studied.

Full Information

First Posted
December 10, 2007
Last Updated
October 18, 2017
Sponsor
Mayo Clinic
Collaborators
Polycystic Kidney Disease Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT00571909
Brief Title
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study
Official Title
Evaluation and Treatment of Chronic Pain in Autosomal Dominant Polycystic Kidney Disease
Study Type
Interventional

2. Study Status

Record Verification Date
October 2017
Overall Recruitment Status
Completed
Study Start Date
May 2007 (undefined)
Primary Completion Date
January 2016 (Actual)
Study Completion Date
January 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mayo Clinic
Collaborators
Polycystic Kidney Disease Foundation

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
We will enroll 20 patients to evaluate the effectiveness of a new operation known as videothoracoscopic splanchnicectomy (VSPL) for management of chronic kidney pain. This study is being done to test if this procedure is effective in controlling chronic kidney pain.
Detailed Description
Some patients with autosomal dominant polycystic kidney disease (ADPKD) have intractable disabling chronic kidney pain. Among methods used to manage these patients, removal of the nerve supply to the kidney by Videothoracoscopic excision of Splanchnic nerve (videothoracoscopic splanchnicectomy - VSPL) is one of the most promising procedures. Few of these procedures have been performed in ADPKD patients (and in only one patient using the less invasive thoracic approach). We recently performed VSPL on two patients who had chronic pain. Both had initial improvement but have had very short follow up. This study should improve understanding of the molecular mechanisms and mediators of kidney pain and provide the hope of an effective procedure to ADPKD patients with chronic kidney pain. We are now enrolling patients to study the effectiveness of the VSPL operation, collecting information on pain intensity, quality of life, kidney blood flow, kidney/cyst volume and also to study the involved pain pathways. Baseline Visit - The patient will also have a complete physical exam and have the kidney's filtration rate measured. Urine and blood tests are performed at each evaluation. You will have an MRI performed of your kidneys. There is no radiation exposure associated with this procedure. You will also be asked to complete Quality of Life (QOL), HALT Pain, and Depression Score questionnaires. These will take approximately 15 minutes to complete and will be repeated at each evaluation. The VSPL operation will be done within approximately 1 week of your Baseline Visit and is considered part of your clinical care and not part of the research.In this procedure the surgeon approaches the nerves supplying the kidneys through the chest wall, using 3 small incisions. He locates these nerves, then cuts a piece of them and removes it from the chest cavity.You will be released from the hospital when your pain is controlled on oral medications. 1 Month Visit-You will be asked to return to the Mayo Clinic one month after your VSPL procedure for a physical exam and completion of the questionnaires.If unable to return to the Mayo Clinic this evaluation can be done with your local doctor. 3 Month Visit-The 3 Month Visit will be identical to the Baseline visit. You will have a physical exam, blood and urine samples, MRI of your kidneys, Iothalamate Clearance, and the three questionnaires to complete. 6 Months: The questionnaires will be mailed to you for completion. 12 Month Visit-The 12 Month Visit is identical to the 1 Month visit. You will be asked to return to the Mayo Clinic for a physical exam and completion of the questionnaires. 2 Year Visit-The 2 Year Visit will be identical to the Baseline visit. You will have a physical exam, blood and urine samples, MRI of your kidneys, measurement of kidney filtration and complete the three questionnaires.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Kidney, Polycystic, Autosomal Dominant
Keywords
Polycystic Kidney Disease, Chronic Kidney Pain, Autosomal Dominant Polycystic Kidney, Kidney Cyst, VSPL, video thoracoscopic splanchnicectomy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
18 (Actual)

8. Arms, Groups, and Interventions

Arm Title
video thoracoscopic splanchnicectomy (VSPL)
Arm Type
Experimental
Intervention Type
Procedure
Intervention Name(s)
video thorascopic splanchnicectomy (VSPL)
Intervention Description
VSPL is a minimally invasive technique using 1-2cm incisions through which a camera and surgical tools are placed inside the thoracic cavity and the idea of the procedure is to cut the pain pathway linking the splanchnic ganglion with pain centers in the hypothalamus
Primary Outcome Measure Information:
Title
Improvement in pain control and quality of life
Time Frame
2 yrs
Secondary Outcome Measure Information:
Title
Changes in urine biomarkers compared to pre-operation values within patients will be compared. Changes in kidney volume, kidney cyst volume, and kidney blood flow before and after the operation will be studied.
Time Frame
3 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 18 years or older Diagnosis of Autosomal Dominant Polycystic Kidney Disease (ADPKD) History of debilitating kidney pain for at least 6 month. Other methods of pain management will have been appropriately considered and used when feasible and indicated. Patient fit for general anesthesia Must be able to travel to Mayo Clinic Rochester for 3 visits Must be able to cover the cost of the surgery and post operative care. Exclusion Criteria: Pregnant women (must have a confirmed negative pregnancy test) Nursing women Creatinine > 3mg/dl, or hemodialysis dependent Cancer and other major systemic diseases that could prevent follow-up or data interpretation Neurologic or psychologic conditions preventing appropriate informed consent Uncontrolled hypertension(SBP > 160; DBP >100)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marie C. Hogan, M.D., Ph.D.
Organizational Affiliation
Mayo Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mayo Clinic
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55905
Country
United States

12. IPD Sharing Statement

Links:
URL
http://clinicaltrials.mayo.edu
Description
Mayo Clinic Clinical Trials

Learn more about this trial

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study

We'll reach out to this number within 24 hrs